MedTrace Logo

NSAID vs Steroid in Trabeculectomy Wound Management

NCT03751059 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 150

Last updated 2020-10-19

No results posted yet for this study

Summary

This study will examine the efficacy of steroid vs NSAID treatment in relation to trabeculectomy wound management. Eligible study participants will be randomized to receive either steroid or NSAID topical treatment one week post-trabeculectomy. Each group will dose with their assigned study treatment until three months post-trabeculectomy. Study participants will be followed for twelve months post-trabeculectomy.

Conditions

Interventions

DRUG

Bromfenac 0.07% Oph Susp

Bromfenac 0.07% Oph Susp to be used post-operatively (week 1 to month 3) by one treatment group.

DRUG

Dexamethasone

Topical dexamethasone to be used by all study participants for one week pre-trabeculectomy and by all study participants for one week post-trabeculectomy. At one week post-op, one of the treatment groups will continue to dose with dexamethasone.

Sponsors & Collaborators

  • Glaucoma Research Society of Canada

    collaborator OTHER

  • Cindy Hutnik

    lead OTHER

Principal Investigators

  • Cindy Hutnik, MD · Ivey Eye Institute

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-11-30
Primary Completion
2021-09-30
Completion
2021-12-31

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03751059 on ClinicalTrials.gov